Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Assets Average (2021 - 2025)

Historic Assets Average for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to $704.2 million.

  • Bioventus' Assets Average fell 981.54% to $704.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $704.2 million, marking a year-over-year decrease of 981.54%. This contributed to the annual value of $769.4 million for FY2024, which is 2952.49% down from last year.
  • Per Bioventus' latest filing, its Assets Average stood at $704.2 million for Q3 2025, which was down 981.54% from $699.1 million recorded in Q2 2025.
  • Bioventus' Assets Average's 5-year high stood at $1.4 billion during Q4 2022, with a 5-year trough of $568.8 million in Q2 2021.
  • Its 5-year average for Assets Average is $882.8 million, with a median of $802.6 million in 2024.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 11300.32% in 2022, then plummeted by 4145.77% in 2023.
  • Quarter analysis of 5 years shows Bioventus' Assets Average stood at $940.3 million in 2021, then skyrocketed by 47.33% to $1.4 billion in 2022, then plummeted by 41.46% to $811.0 million in 2023, then decreased by 7.68% to $748.7 million in 2024, then fell by 5.95% to $704.2 million in 2025.
  • Its Assets Average was $704.2 million in Q3 2025, compared to $699.1 million in Q2 2025 and $709.7 million in Q1 2025.